Rad AI

AI radiology reporting at scale

Rad AI is a healthcare technology company that has successfully commercialized generative AI products. Their solutions are widely adopted in US health systems and radiology practices, demonstrating significant efficiency improvements.

Shareable draft

Check out Rad AI on @MedStartr Today Rad AI is a healthcare technology company that has successfully commercialized generative AI products. Their solutions are widely adopted in US health systems and radiology practices, demonstrating significant efficiency improvements. #Neurology #MentalBehavioralHealth #CancerOncology #ClinicalDocumentation #MedMo #MedStartrVentures

https://www.medstartr.ai/s/LcZndIhFdfY

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in Rad AI

1 engagement

How We Help

Problem Statement

Healthcare systems and radiology practices face inefficiencies in their operations.

Core Technology

generative AI

Key Differentiators

First to successfully commercialize generative AI product in healthcare

Clinical Focus

Radiology

Company Info

Business Model: B2B
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.rad.ai/

Disease Areas

Neurology Mental Health Cancer & Oncology

Technologies

Clinical Documentation AIGenerative AIAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

FDA-cleared as de novo diagnostic AI; first generative AI to achieve widespread adoption in US radiology; winner of AuntMinnie Best New Radiology Software 2023; CB Insights AI 100 and Digital Health 50

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Rad AI?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.